Publications by authors named "P Cornes"

Claim this Profile
B
Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings.
Tore K Kvien, Neil Betteridge, Ines Brückmann, Wolfram Bodenmüller, Galyna Bryn, Paul Cornes

BioDrugs· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential role of biosimilars in healthcare sustainability in Latin America.
Rony Schaffel, Paul Cornes, Manuel A Espinoza, David Gómez-Almaguer, Angelo Maiolino

Expert Opin Biol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of clinical trials research in inherited ophthalmic disease.
Vincent Ng, Cheuk Ying Li, Paul Cornes, Marcela Votruba

Ophthalmic Genet· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging the holistic benefits of biosimilars in Europe - part 2: how payers can safeguard the future of a healthy biosimilar market environment.
Jorge Mestre-Ferrandiz, Marcin Czech, Josef S Smolen, Paul Cornes, Matti S Aapro

Expert Rev Pharmacoecon Outcomes Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capturing the holistic value of biosimilars in Europe - part 1: a historical perspective.
Jorge Mestre-Ferrandiz, Marcin Czech, Josef S Smolen, Paul Cornes, Matti S Aapro

Expert Rev Pharmacoecon Outcomes Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis